You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
Nighttime relief is on the way.
A 756-patient study of Lantus (insulin glargine), the 24-hour basal insulin from Aventis, revealed that when compared to NPH, nearly 25 percent more patients in the Lantus group achieved the target A1C of 7 percent or less without an episode of nighttime hypoglycemia (low blood glucose).
The 24-week multi-center randomized study enrolled overweight type 2 men and women with inadequate blood glucose control (A1Cs greater than 7.5 percent) who were using one or two oral diabetes drugs. The added bedtime dose of either Lantus or NPH insulin was titrated as needed, seeking a target morning fasting blood glucose of 100 mg/dl or less.
-Diabetes Care, November 2003
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.